Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01191151 · ClinicalTrials.gov registry record
Web Based Orthopaedic Sports Medicine Registry
A clinical trial, sponsored by Arthrex.
- Terminated
- Registry status
- 12,500
- Enrollment target
NCT01191151: Clinical Trial study, sponsored by Arthrex.
NCT01191151 is a clinical trial that was terminated before completion, run by Arthrex. The registered enrollment target is 12,500 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01191151 was terminated before completion, sponsored by Arthrex.
- TERMINATED
- Registry status
- 12,500 participants
- Enrollment target
Study Summary
The purpose of this study is to establish an international, web based clinical registry to collect baseline characteristics of patients undergoing orthopaedic, sports medicine, arthroscopy, and related surgery, and the subsequent outcomes and cost-effectiveness associated with the surgical procedures and nonoperative treatments.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12,500 participants |
| Start Date | 2010-09 |
| Est. Completion | 2023-07-30 |
Why NCT01191151 stopped before completion
NCT01191151 is an observational study that tracks outcomes without assigning an intervention. Its 12,500 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT01191151 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01191151 about?
NCT01191151 is a clinical study titled "Web Based Orthopaedic Sports Medicine Registry". The purpose of this study is to establish an international, web based clinical registry to collect baseline characteristics of patients undergoing orthopaedic, sports medicine, arthroscopy, and related surgery, and the subsequent outcomes and cost-effectiveness associated with the surgical procedure...
What is the current status of trial NCT01191151?
This trial is currently terminated. The enrollment target is 12,500 participants. The study started on 2010-09. Estimated completion is 2023-07-30.
Who is sponsoring clinical trial NCT01191151?
This trial is sponsored by Arthrex, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04888832 · 12,500 participants · NA
The Effect of Work Requirements in SNAP in Virginia
- NCT05452941 · 12,500 participants
A Study to Learn About How 20-Valent Pneumococcal Conjugate Vaccine Works in a Real-world Setting
- NCT07069556 · 12,500 participants
ColoSense Post-Approval Study
- NCT07037433 · 12,800 participants · Phase 3
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia